On 21st September we held our fourth ‘Science for Tomorrow’s Neurosurgery’ PPI group meeting online, with presentations from Oscar, Matt and Silvère. Presentations focused on an update from the NeuroHSI trial, with clear demonstration of improvements in resolution of the HSI images we are now able to acquire; this prompted real praise from our patient representatives, which is extremely reassuring for the trial going forward. We also took this opportunity to announce the completion of the first phase of NeuroPPEYE, in which we aim to use HSI to quantify tumour fluorescence beyond that which the human eye can see. Discussions were centered around the theme of “what is an acceptable number of participants for proof of concept studies,” generating very interesting points of view that ultimately concluded that there was no “hard number” from the patient perspective, as long as a thorough assessment of the technology had been carried out. This is extremely helpful in how we progress with the trials, particularly NeuroPPEYE, which will begin recruitment for its second phase shortly. Once again, the themes and discussions were summarized in picture format by our phenomenal illustrator, Jenny Leonard (see below) and we are already making plans for our next meeting in February 2024!
We are seeking an interventional image computing researcher to design and translate the next generation of AI-assisted hyperspectral imaging systems for surgical guidance using quantitative fluorescence. The postholder, based within the Department of Surgical & Interventional Engineering at King’s College London, will play a key role in NeuroPPEye a collaborative project with King’s College Hospital and work closely with the project’s industrial collaborator Hypervision Surgical, a King’s spin-out company. A clinical neurosurgery study underpins this collaboration. The successful candidate will work on the resulting neurosurgical data as well as controlled phantom data. They will also have the opportunity to provide insight on how to best acquire prospective data.
We are seeking a Post-doctoral Research Associate to develop novel trustworthy artificial intelligence (AI) algorithms able to extract actionable information from surgical imaging data.
We are working to develop new technologies that combine a new type of camera system, referred to as hyperspectral, with Artificial Intelligence (AI) systems to reveal to neurosurgeons information that is otherwise not visible to the naked eye during surgery. Two studies are currently bringing this “hyperspectral” technology to operating theatres. The NeuroHSI study uses a hyperspectral camera attached to an external scope to show surgeons critical information on tissue blood flow and distinguishes vulnerable structures which need to be protected. The NeuroPPEye study is developing this technology adapted for surgical microscopes, to guide tumour surgery.
We are seeking a motivated research nurse/coordinator to support our NeuroHSI and NeuroPPEye project.
The post will be a Band 6 level Neurosurgery affiliated research nurse/coordinator to work within the neuroscience division at KCH. This is a full-time post, initially until end of August 2023 with a view to be extended by 6 - 12 months. The successful applicant will work across several neurosurgery sub-specialities with a particular focus on neuro-oncology and translational healthcare technology in neurosurgery. The applicate will work on research and clinical trials listed in the Department of Heath national portfolio, principally involving the development and evaluation of advanced smart camera technology for use during surgery. The post holder will work under the supervision of Mr Jonathan Shapey (Senior Clinical Lecturer and Consultant Neurosurgeon), Professor Keyoumars Ashkan (Professor of Neurosurgery) and the management of Alexandra Rizos, Neuroscience Research Manager. Some experience in clinical research and knowledge of good clinical practice would be beneficial.
We are working to develop new technologies that combine a new type of camera system, referred to as hyperspectral, with Artificial Intelligence (AI) systems to reveal to neurosurgeons information that is otherwise not visible to the naked eye during surgery. Two studies are currently bringing this “hyperspectral” technology to operating theatres. The NeuroHSI study uses a hyperspectral camera attached to an external scope to show surgeons critical information on tissue blood flow and distinguishes vulnerable structures which need to be protected. The NeuroPPEye study is developing this technology adapted for surgical microscopes, to guide tumour surgery.